Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival.

MLA

Lee, Woohyung, et al. “Metabolic Activity by FDG-PET/CT after Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer and Association with Survival.” The British Journal of Surgery, vol. 109, no. 1, Dec. 2021, pp. 61–70. EBSCOhost, https://doi.org/10.1093/bjs/znab229.

APA

Lee, W., Oh, M., Kim, J. S., Park, Y., Kwon, J. W., Jun, E., Song, K. B., Lee, J. H., Hwang, D. W., Yoo, C., Kim, K.-P., Jeong, J. H., Chang, H.-M., Ryoo, B.-Y., Park, S. Y., & Kim, S. C. (2021). Metabolic activity by FDG-PET/CT after neoadjuvant chemotherapy in borderline resectable and locally advanced pancreatic cancer and association with survival. The British Journal of Surgery, 109(1), 61–70. https://doi.org/10.1093/bjs/znab229

Chicago

Lee, Woohyung, Minyoung Oh, Jae Seung Kim, Yejong Park, Jae Woo Kwon, Eunsung Jun, Ki Byung Song, et al. 2021. “Metabolic Activity by FDG-PET/CT after Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer and Association with Survival.” The British Journal of Surgery 109 (1): 61–70. doi:10.1093/bjs/znab229.